Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313648339> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W4313648339 endingPage "205521732211496" @default.
- W4313648339 startingPage "205521732211496" @default.
- W4313648339 abstract "Background Cladribine is a useful therapeutic option in RRMS with moderate to high disease activity. Its oral formulation and tolerability make it a useful alternative to infusion therapies. Cladribine is known to deplete CD19 + B lymphocytes, but its effect on immunoglobulin subsets is unclear. Objective To identify whether cladribine therapy in pwMS reduces immunoglobulin subset levels as a surrogate marker of infection risk. Methods A ‘real-world’ retrospective analysis of 341 pwMS presenting to a single tertiary centre between March 2017 and July 2021. Differences in immunoglobulin levels between cladribine, other disease-modifying therapies and no active treatment were assessed using a univariate ANOVA. Results Three hundred and forty-one patients had immunoglobulin levels assessed, with 29 patients treated with cladribine. The mean IgG, IgM and IgA levels on cladribine therapy were 10.44 ± 0.40, 0.99 ± 0.09 and 2.04 ± 0.18 g/L respectively. These were not significantly different from patients not on active treatment. There was a statistically significant reduction in IgG and IgM levels for patients treated with ocrelizumab (9.37 ± 0.19 and 0.68 ± 0.04 g/L) and natalizumab (8.72 ± 0.53 and 0.69 ± 0.12 g/L) compared to patients not on treatment. Conclusion Cladribine therapy for RRMS was not associated with immunoglobulin subset deficiencies. This is contrasted to ocrelizumab and natalizumab which demonstrate significant reductions in both IgG and IgM levels." @default.
- W4313648339 created "2023-01-07" @default.
- W4313648339 creator A5014375641 @default.
- W4313648339 creator A5020944412 @default.
- W4313648339 creator A5030736390 @default.
- W4313648339 creator A5059129245 @default.
- W4313648339 creator A5078442898 @default.
- W4313648339 date "2023-01-01" @default.
- W4313648339 modified "2023-09-27" @default.
- W4313648339 title "The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis" @default.
- W4313648339 cites W1528445565 @default.
- W4313648339 cites W1890033097 @default.
- W4313648339 cites W1978971614 @default.
- W4313648339 cites W2016149155 @default.
- W4313648339 cites W2017431273 @default.
- W4313648339 cites W2018071669 @default.
- W4313648339 cites W2078641935 @default.
- W4313648339 cites W2095109014 @default.
- W4313648339 cites W2128361812 @default.
- W4313648339 cites W2139204856 @default.
- W4313648339 cites W2153918104 @default.
- W4313648339 cites W2751578374 @default.
- W4313648339 cites W2833295077 @default.
- W4313648339 cites W2887206114 @default.
- W4313648339 cites W2899093568 @default.
- W4313648339 cites W2900348232 @default.
- W4313648339 cites W2900596677 @default.
- W4313648339 cites W2914053307 @default.
- W4313648339 cites W2914770914 @default.
- W4313648339 cites W2947252334 @default.
- W4313648339 cites W2949139014 @default.
- W4313648339 cites W2975094970 @default.
- W4313648339 cites W3107503536 @default.
- W4313648339 cites W3158831599 @default.
- W4313648339 cites W3159017041 @default.
- W4313648339 cites W3199233027 @default.
- W4313648339 cites W3205770224 @default.
- W4313648339 cites W3216401883 @default.
- W4313648339 doi "https://doi.org/10.1177/20552173221149688" @default.
- W4313648339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36636583" @default.
- W4313648339 hasPublicationYear "2023" @default.
- W4313648339 type Work @default.
- W4313648339 citedByCount "0" @default.
- W4313648339 crossrefType "journal-article" @default.
- W4313648339 hasAuthorship W4313648339A5014375641 @default.
- W4313648339 hasAuthorship W4313648339A5020944412 @default.
- W4313648339 hasAuthorship W4313648339A5030736390 @default.
- W4313648339 hasAuthorship W4313648339A5059129245 @default.
- W4313648339 hasAuthorship W4313648339A5078442898 @default.
- W4313648339 hasBestOaLocation W43136483391 @default.
- W4313648339 hasConcept C126322002 @default.
- W4313648339 hasConcept C159654299 @default.
- W4313648339 hasConcept C197934379 @default.
- W4313648339 hasConcept C203014093 @default.
- W4313648339 hasConcept C2778375690 @default.
- W4313648339 hasConcept C2778843634 @default.
- W4313648339 hasConcept C2779200787 @default.
- W4313648339 hasConcept C2780640218 @default.
- W4313648339 hasConcept C2780653079 @default.
- W4313648339 hasConcept C2780898057 @default.
- W4313648339 hasConcept C2781004633 @default.
- W4313648339 hasConcept C71924100 @default.
- W4313648339 hasConcept C90924648 @default.
- W4313648339 hasConceptScore W4313648339C126322002 @default.
- W4313648339 hasConceptScore W4313648339C159654299 @default.
- W4313648339 hasConceptScore W4313648339C197934379 @default.
- W4313648339 hasConceptScore W4313648339C203014093 @default.
- W4313648339 hasConceptScore W4313648339C2778375690 @default.
- W4313648339 hasConceptScore W4313648339C2778843634 @default.
- W4313648339 hasConceptScore W4313648339C2779200787 @default.
- W4313648339 hasConceptScore W4313648339C2780640218 @default.
- W4313648339 hasConceptScore W4313648339C2780653079 @default.
- W4313648339 hasConceptScore W4313648339C2780898057 @default.
- W4313648339 hasConceptScore W4313648339C2781004633 @default.
- W4313648339 hasConceptScore W4313648339C71924100 @default.
- W4313648339 hasConceptScore W4313648339C90924648 @default.
- W4313648339 hasIssue "1" @default.
- W4313648339 hasLocation W43136483391 @default.
- W4313648339 hasLocation W43136483392 @default.
- W4313648339 hasLocation W43136483393 @default.
- W4313648339 hasOpenAccess W4313648339 @default.
- W4313648339 hasPrimaryLocation W43136483391 @default.
- W4313648339 hasRelatedWork W2272446420 @default.
- W4313648339 hasRelatedWork W2564051232 @default.
- W4313648339 hasRelatedWork W2959474424 @default.
- W4313648339 hasRelatedWork W2980318299 @default.
- W4313648339 hasRelatedWork W3030177861 @default.
- W4313648339 hasRelatedWork W3085502568 @default.
- W4313648339 hasRelatedWork W3087259986 @default.
- W4313648339 hasRelatedWork W3167922398 @default.
- W4313648339 hasRelatedWork W3206160011 @default.
- W4313648339 hasRelatedWork W3206571000 @default.
- W4313648339 hasVolume "9" @default.
- W4313648339 isParatext "false" @default.
- W4313648339 isRetracted "false" @default.
- W4313648339 workType "article" @default.